Cardiovascular Surgery Devices And Equipment Market Report 2026

Cardiovascular Surgery Devices And Equipment Market Overview

• Cardiovascular Surgery Devices And Equipment market size has reached to $1.8 billion in 2025 • Expected to grow to $2.06 billion in 2030 at a compound annual growth rate (CAGR) of 3.1% • Growth Driver: Rising Geriatric Population Fueling The Growth Of The Cardiovascular Surgical Devices Market Due To Increasing Age-Related Healthcare Needs • Market Trend: GE HealthCare Launches CardioVisio for AFib to Enhance Precision Care and Streamline Clinical Workflows • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Cardiovascular Surgery Devices And Equipment Market?

Cardiovascular surgery devices and equipment are used in cardiac surgery and other cardiovascular procedures performed to repair structural defects of the cardiovascular system and damaged or blocked valves and vessels. The main product types in the cardiovascular surgery devices and equipment are beating heart surgery systems, cardiopulmonary bypass equipment, cardiac ablation devices, and perfusion disposables. Cardiopulmonary bypass equipment is used in open-heart surgeries and is operated by perfectionists. The various applications are congenital heart defects, cardiac arrhythmia, coronary heart disease, congestive heart failure, and other applications. These are used in home and ambulatory care, hospitals, diagnostic laboratories, and research laboratories.

What Is The Cardiovascular Surgery Devices And Equipment Market Growth Forecast?

The cardiovascular surgery devices and equipment market size is expected to see steady growth in the next few years. It will grow to $2.06 billion in 2030 at a compound annual growth rate (CAGR) of 3.1%. The growth in the forecast period can be attributed to increasing demand for less invasive cardiac interventions, rising investments in advanced surgical platforms, expansion of hybrid cardiac operating rooms, growing use of ai-assisted surgical planning, continuous innovation in cardiovascular surgical devices. Major trends in the forecast period include increasing adoption of minimally invasive cardiac surgery devices, rising use of advanced cardiac ablation technologies, growing precision in cardiopulmonary bypass systems, expansion of beating heart surgery techniques, enhanced focus on surgical outcome optimization.

Global Cardiovascular Surgery Devices And Equipment Market Segmentation

1) By Product Type: Beating heart surgery systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, Perfusion Disposables 2) By Application: Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, Other Applications 3) By End User: Ambulatory Surgical Centers, Hospitals, Cardiac Specialty Centers, Research Laboratories Subsegments: 1) By Beating Heart Surgery Systems: Stabilization Systems, Tissue Stabilizers, Coronary Artery Bypass Surgery Systems, Other Beating Heart Surgery Devices 2) By Cardiopulmonary Bypass Equipment: Heart-Lung Machines, Oxygenators, Cannulas, Tubing Packs, Cardioplegia Delivery Systems, Other Cardiopulmonary Bypass Equipment 3) By Cardiac Ablation Devices: Radiofrequency Ablation Devices, Cryoablation Devices, Laser Ablation Devices, Microwave Ablation Devices, Other Cardiac Ablation Devices 4) By Perfusion Disposables: Blood Oxygenators, Perfusion Cannulas, Tubing Sets, Filters, Blood Reservoirs, Other Perfusion Disposables

What Is The Driver Of The Cardiovascular Surgery Devices And Equipment Market?

The rising geriatric population is expected to propel the growth of the cardiovascular surgical devices market going forward. Geriatric population refers to individuals aged 65 years and older who are considered older adults within a population. They are characterized by increased healthcare needs due to age-related physiological changes and a higher prevalence of chronic conditions. Cardiovascular surgical devices help the geriatric population by enabling safer, minimally invasive procedures that address age-related heart conditions and improve overall survival and quality of life. For instance, in October 2025, according to the World Health Organization, a Switzerland-based intergovernmental organization, between 2020 and 2050, the number of people 80 years of age or older is predicted to treble to 426 million. Therefore, the rising geriatric population is driving the growth of the cardiovascular surgical devices market.

Key Players In The Global Cardiovascular Surgery Devices And Equipment Market

Major companies operating in the cardiovascular surgery devices and equipment market are Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Abiomed Inc., TransMedics, Terumo Cardiovascular Systems Corporation, Edwards Lifesciences Corporation, Medtronic plc, Cyberheart Incorporated, Thoratec Corporation, Cordis Corporation, Getinge Group, Atrion Corporation, Sorin S.p.A., Bioventrix Inc., Maquet GmbH & Co. KG, EndoPhotonix Inc., LivaNova PLC, CryoLife Inc., Artivion Inc.

Global Cardiovascular Surgery Devices And Equipment Market Trends and Insights

Major companies are investing in the companies operating in the cardiovascular surgery devices and Equipment market that are focusing on developing innovative solutions, such as CardioVisio for Atrial Fibrillation (AFib), to improve early diagnosis, enhance patient outcomes, and streamline treatment pathways. CardioVisio for Atrial Fibrillation (AFib) refers to an advanced diagnostic and monitoring solution designed to detect and manage AFib, a common type of irregular heart rhythm. For instance, in August 2023, GE HealthCare, a US-based medical technology company, launched CardioVisio for Atrial Fibrillation (AFib), a digital clinical decision support tool aimed at enhancing precision care for patients with AFib. Introduced at the ESC Congress 2023, this innovative solution integrates longitudinal patient data from various sources, providing clinicians with a comprehensive view of heart health. By offering evidence-based recommendations aligned with AFib guidelines, CardioVisio streamlines clinical workflows and improves adherence to best practices.

What Are Latest Mergers And Acquisitions In The Cardiovascular Surgery Devices And Equipment Market?

In May 2024, Johnson & Johnson, a US-based pharmaceutical company, acquired Shockwave Medical for an undisclosed amount. With this acquisition, Johnson & Johnson aims to expand its cardiovascular portfolio and strengthen its position in innovative, minimally invasive vascular treatment technologies. Shockwave Medical Inc. is a US-based company that develops and commercializes innovative products for the treatment of cardiovascular disease.

Regional Outlook

North America was the largest region in the global cardiovascular surgery devices and equipment market in 2025. Western Europe was the second-largest region in the global cardiovascular surgery devices and equipment market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

What Defines the Cardiovascular Surgery Devices And Equipment Market?

The cardiovascular surgery devices and equipment market consist of sales of perfusion disposables, beating heart surgery systems, cardiopulmonary bypass equipment, and cardiac ablation devices that are used for cardiovascular surgeries. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.